QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (92) Citing Articles via Google Scholar Google Scholar Articles by Gubellini, P. Articles by Maccarrone, M. Search for Related Content PubMed PubMed Citation Articles by Gubellini, P. Articles by Maccarrone, M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 15, 2002, 22(16):6900-6907

Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission

Paolo Gubellini^{1, 3}, Barbara Picconi^{1, 4}, Monica Bari², Natalia Battista², Paolo Calabresi^{1, 4}, Diego Centonze^{1, 4}, Giorgio Bernardi^{1, 4}, Alessandro Finazzi-Agrò², and Mauro Maccarrone²

Dipartimentos di ¹ Neuroscienze and ² Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Roma "Tor Vergata", 00133 Roma, Italy, ³ Istituto di Neurobiologia e Medicina Molecolare, Consiglio Nazionale delle Ricerche, 00133 Roma, Italy, and ⁴ Istituto di Ricovero e Cura a Carattere Scientifico Fondazione "Santa Lucia", 00179 Roma, Italy

Cannabinoid receptors and their endogenous ligands have been recently identified in the brain as potent inhibitors of neurotransmitter release. Here we show that, in a rat model of Parkinson's disease induced by unilateral nigral lesion with 6-hydroxydopamine (6-OHDA), the striatal levels of anandamide, but not that of the other endocannabinoid 2-arachidonoylglycerol, were increased. Moreover, we observed a decreased activity of the anandamide membrane transporter (AMT) and of the anandamide hydrolase [fatty acid amide hydrolase (FAAH)], whereas the binding of anandamide to cannabinoid receptors was unaffected. Spontaneous glutamatergic activity recorded from striatal spiny neurons was higher in 6-OHDA-lesioned rats. Inhibition of AMT by N-(4-hydroxyphenyl)-arachidonoylamide (AM-404) or by VDM11, or stimulation of the cannabinoid CB1 receptor by HU-210 reduced glutamatergic spontaneous activity in both naïve and 6-OHDA-lesioned animals to a similar extent. Conversely, the FAAH inhibitors phenylmethylsulfonyl fluoride and methyl-arachidonoyl fluorophosphonate were much more effective in 6-OHDA-lesioned animals. The present study shows that inhibition of anandamide hydrolysis might represent a possible target to decrease the abnormal cortical glutamatergic drive in Parkinson's disease.

Key words: anandamide; CB1 receptor; dopamine; excitatory amino acids; glutamate; Parkinson's disease; striatum

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22166900-08$05.00/0

This article has been cited by other articles:

				J. Brotchie and C. Fitzer-Attas Mechanisms compensating for dopamine loss in early Parkinson disease Neurology, February 17, 2009; 72(7_Supplement_2): S32 - S38. [Abstract] [Full Text] [PDF]

				L. Liang, M. R. DeLong, and S. M. Papa Inversion of Dopamine Responses in Striatal Medium Spiny Neurons and Involuntary Movements J. Neurosci., July 23, 2008; 28(30): 7537 - 7547. [Abstract] [Full Text] [PDF]

				C. Blomeley and E. Bracci Substance P depolarizes striatal projection neurons and facilitates their glutamatergic inputs J. Physiol., April 15, 2008; 586(8): 2143 - 2155. [Abstract] [Full Text] [PDF]

				X. Cao, L. Liang, J. R. Hadcock, P. A. Iredale, D. A. Griffith, F. S. Menniti, S. Factor, J. T. Greenamyre, and S. M. Papa Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 318 - 326. [Abstract] [Full Text] [PDF]

				D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, F. Fezza, V. De Chiara, L. Battistini, G. Bernardi, S. Bernardini, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis Brain, October 1, 2007; 130(10): 2543 - 2553. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				C. Escartin, E. Brouillet, P. Gubellini, Y. Trioulier, C. Jacquard, C. Smadja, G. W. Knott, L. K.-L. Goff, N. Deglon, P. Hantraye, et al. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J. Neurosci., May 31, 2006; 26(22): 5978 - 5989. [Abstract] [Full Text] [PDF]

				M. Yamasaki, K. Hashimoto, and M. Kano Miniature Synaptic Events Elicited by Presynaptic Ca2+ Rise Are Selectively Suppressed by Cannabinoid Receptor Activation in Cerebellar Purkinje Cells J. Neurosci., January 4, 2006; 26(1): 86 - 95. [Abstract] [Full Text] [PDF]

				A. Kofalvi, R. J. Rodrigues, C. Ledent, K. Mackie, E. S. Vizi, R. A. Cunha, and B. Sperlagh Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis J. Neurosci., March 16, 2005; 25(11): 2874 - 2884. [Abstract] [Full Text] [PDF]

				S. R. Kim, D. Y. Lee, E. S. Chung, U. T. Oh, S. U. Kim, and B. K. Jin Transient Receptor Potential Vanilloid Subtype 1 Mediates Cell Death of Mesencephalic Dopaminergic Neurons In Vivo and In Vitro J. Neurosci., January 19, 2005; 25(3): 662 - 671. [Abstract] [Full Text] [PDF]

				B. Picconi, D. Centonze, S. Rossi, G. Bernardi, and P. Calabresi Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism Brain, July 1, 2004; 127(7): 1661 - 1669. [Abstract] [Full Text] [PDF]

				M. Maccarrone, M. DeFelici, F.G. Klinger, N. Battista, F. Fezza, E. Dainese, G. Siracusa, and A. Finazzi-Agro Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus Mol. Hum. Reprod., April 1, 2004; 10(4): 215 - 221. [Abstract] [Full Text] [PDF]

				M. Maccarrone, M. Di Rienzo, N. Battista, V. Gasperi, P. Guerrieri, A. Rossi, and A. Finazzi-Agro The Endocannabinoid System in Human Keratinocytes: EVIDENCE THAT ANANDAMIDE INHIBITS EPIDERMAL DIFFERENTIATION THROUGH CB1 RECEPTOR-DEPENDENT INHIBITION OF PROTEIN KINASE C, ACTIVATING PROTEIN-1, AND TRANSGLUTAMINASE J. Biol. Chem., September 5, 2003; 278(36): 33896 - 33903. [Abstract] [Full Text] [PDF]

				S. Patel, D. J. Rademacher, and C. J. Hillard Differential Regulation of the Endocannabinoids Anandamide and 2-Arachidonylglycerol within the Limbic Forebrain by Dopamine Receptor Activity J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 880 - 888. [Abstract] [Full Text] [PDF]

				M. Maccarrone, M. Bari, M. Di Rienzo, A. Finazzi-Agro, and A. Rossi Progesterone Activates Fatty Acid Amide Hydrolase (FAAH) Promoter in Human T Lymphocytes through the Transcription Factor Ikaros: EVIDENCE FOR A SYNERGISTIC EFFECT OF LEPTIN J. Biol. Chem., August 29, 2003; 278(35): 32726 - 32732. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help